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ABSTRACT 
Background and objective: Peak bone mass, the maximal bone mass attained in 
young adulthood, is an important factor of the lifetime risk of developing 
osteoporosis. The aim of this thesis was to study the development of bone mineral 
density (BMD) and bone geometry around the time of peak bone mass in men, and 
also to investigate the association between pubertal timing, fracture history, bone 
turnover markers and BMD and bone geometry in young men. 
Methods: The studies included in the thesis were performed within the Gothenburg 
Osteoporosis and Obesity Determinants (GOOD) study, a well-characterized 
population-based cohort including 1068 men between 18-20 years of age at baseline. 
At baseline and follow-up five years later, measurements of bone density, bone mass 
and bone geometry were assessed with dual energy X-ray absorptiometry (DXA) and 
peripheral quantitative computed tomography (pQCT). Blood samples were drawn to 
measure bone turnover markers. A self-administered questionnaire was used to 
collect information about physical activity, nutritional intake, smoking and previous 
fracture. Reported fractures were verified in X-ray registers. 
Results: Previous fracture was associated with lower BMD at age 19, and especially 
with reduced trabecular volumetric BMD (vBMD) of the radius. Between 19 and 24 
years of age, lumbar spine areal BMD (aBMD) increased while femoral neck aBMD 
decreased. Radius aBMD increased, due to increased cortical thickness and 
continuing mineralization. Men with late puberty had larger gains in aBMD, vBMD, 
and bone size, reflecting a catch up in bone acquisition in young adulthood in men 
with late puberty. A high level of osteocalcin (a bone turnover marker) was 
associated with larger gains in aBMD, vBMD, and bone size between 19 and 24 
years. 
Conclusion: In young adult men between 19 and 24 years, aBMD of the lumbar 
spine and the radius continued to increase, while aBMD of the femoral neck already 
started to decrease. Late puberty and high level of osteocalcin were associated with 
greater increases in aBMD, vBMD and bone size during this period. A previous 
fracture was a risk factor for low BMD in young men. 
Keywords: peak bone mass, bone mineral density, bone development, fracture, 
young adulthood, men  
 SAMMANFATTNING PÅ SVENSKA 
Bakgrund: Den maximala benmassan (peak bone mass) som uppnås i ung vuxen 
ålder, är en viktig faktor för risken att senare i livet drabbas av benskörhet 
(osteoporos) och därmed ökad risk för benbrott (frakturer). En hög maximal 
benmassa minskar risken för benskörhet.  
Frågeställning: I den här avhandlingen studerades utvecklingen av benmassa, 
bentäthet och benstorlek hos unga män vid tiden för maximal benmassa. Vi 
undersökte om denna utveckling skilde sig åt beroende på tidpunkt för pubertet och 
beroende på nivåer av benomsättningsmarkörer som kan mätas i blodprov. Vi 
studerade också sambandet mellan fraktur under uppväxten och bentäthet och 
benstorlek i ung vuxen ålder. 
Metod: Delstudierna som ingår i avhandlingen utfördes inom en välkarakteriserad 
populationsbaserad kohort bestående av 1068 unga män som vid studiens start var 
mellan 18 och 20 år gamla (the Gothenburg Obesity and Osteoporosis Determinants 
(GOOD) Study). Vid studiens början och vid uppföljningen fem år senare utfördes 
mätningar av bentäthet, benmassa och benstorlek med hjälp av 
dubbelfotonröntgenabsorbtiometri (DXA) och perifer kvantitativ datortomografi 
(pQCT). Blodprov för mätning av benomsättningsmarkörer togs. Information om 
fysisk aktivitet, näringsintag, rökning och frakturförekomst samlades in med hjälp av 
frågeformulär. Förekomst av frakturer verifierades genom sökning i röntgenarkiv. 
Resultat: Mellan 19 och 24 års ålder minskade bentätheten i höften medan den 
ökade i ländryggen och radius (underarmen). De män som kommit i puberteten sent 
hade lägre bentäthet vid 19 års ålder, men ökade mer i bentäthet mellan 19 och 24 års 
ålder. Vid 24 års ålder hade män med sen pubertet kvarstående lägre bentäthet i 
radius, men inte i höft eller ländrygg. Hög nivå av benomsättningsmarkören 
osteocalcin vid 19 års ålder var kopplad till större ökning i bentäthet och benmassa 
mellan 19 och 24 års ålder. De män som haft en fraktur under uppväxten hade vid 19 
års ålder lägre bentäthet. 
Slutsatser: I ung vuxen ålder (19-24 år) sågs hos män en fortsatt ökning av bentäthet 
i ländrygg och radius, medan bentätheten i höften började sjunka. Sen pubertet och 
hög nivå av osteocalcin var kopplat till större ökning av bentäthet och benstorlek 
under den här perioden. Att ha haft en fraktur under uppväxten var en riskfaktor för 
låg bentäthet hos unga män. 
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DEFINITIONS IN SHORT 
 Bone turnover markers  Substances that reflect bone formation or bone 
resorption and can be measured in samples of 
blood or urine  
Osteoporosis A disease characterized by low bone density 
and microarchitectural deterioration of bone 
tissue, which leads to bone fragility and 
increased risk of fracture  
Peak bone mass The maximal attained bone mass in life 
Peak height velocity 
 
The most rapid longitudinal growth 
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1 INTRODUCTION 
1.1 The skeleton and its functions 
The human skeleton consists of over 200 bones, arranged in a sophisticated 
manner in order to protect vital organs and to allow movement of the body. 
The axial skeleton (skull, vertebrae, rib cage) forms a protective shell around 
the brain, spinal cord and inner organs, while the appendicular skeleton (the 
upper and lower limbs) is crucial for motion. Bones serve as attachment sites 
for muscles and ligaments, thereby enabling the body to move. The skeleton 
is also a reservoir for minerals such as calcium and phosphate, harbors 
hematopoiesis, and is an endocrine organ producing substances such as 
osteocalcin, which influence both bone cells and other cells.  
1.2 Bone structure 
The skeleton is comprised of long (tubular) bones, such as humerus, radius, 
femur and tibia, and flat bones, such as the skull, sternum, scapula and ileum 
(1). Bones have a dense outer shell, called cortex, which is composed of 
compact bone called cortical bone. Cortical bone constitutes 75-80% of the 
skeleton and is found in the shafts of long bones, and on the surface of all 
bones (2). It is composed of lamellae, concentrically arranged around a small 
central canal with a blood vessel, forming a Haversian system (also called 
osteon) (2). Inside the vertebrae and the epiphyses of the long bones, 
trabecular bone is found. Trabecular bone is a rigid meshwork of mineralized 
bone, where number, size and distribution of the trabeculae are arranged in 
order to optimize strength. It constitutes 20% of the total skeletal mass, but 
contributes with 65-70% of the total bone surface and is the most 
metabolically active part of the skeleton, acting as a calcium reservoir (2). 
Trabecular bone is superior in withstanding compressive stress, and therefore 
is the predominant bone in the vertebrae (1). At different sites in the skeleton, 
the proportion of cortical and trabecular bone vary. The distal forearm and 
femoral neck constitute 25% trabecular and 75% cortical bone, whereas the 
vertebraes contain more than two thirds trabecular bone (2). Loss of cortical 
bone and loss of trabecular bone hence predispose to fractures at different 
locations. 
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Figure 1. Schematic view of a longitudinal section through the tibia, a long (tubular) 
bone. 
1.3 The bone cells 
The skeleton consists of three different kinds of bone cells and of 
extracellular matrix (ECM). 90% of the total bone volume is ECM, which 
comprises mineralized matrix, organic matrix, lipids and water (3). 
Hydroxyapatite, (Ca10 (PO4)6 (OH)2)2 is the main component of the 
mineralized matrix and provides the majority of bone strength and stiffness. 
The mineralized matrix accounts for 99% of the body’s storage of calcium 
and 85% of the phosphorous (3). The organic matrix contains mainly type 1 
collagen, as well as proteoglycans, growth factors, and glycoproteins. The 
organic matrix is secreted by osteoblasts and is mineralized within 10-15 
days (3). 
Osteoblasts 
Osteoblasts are responsible for bone formation. They originate from 
mesenchymal stem cells in the bone marrow, and account for 4-6 % of the 
bone cells (4). Osteoblasts build bone by secreting bone proteins and collagen 
that form the bone matrix. Alongside collagen type 1, osteoblasts also 
!"#$%&'(#")$*+%)
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produce osteocalcin (OC), osteonectin, osteopontin and bone sialoprotein (4). 
The average lifespan of an osteoblast is three months (5). The aging 
osteoblast face three possible destinies: undergo apoptosis, become 
embedded in the bone as an osteocyte, or transform into a bone lining cell 
(6). The lining cells are flat cells located on top of a thin layer of 
unmineralized collagen matrix which covers the bone surface. When bone 
remodeling should not occur, they prevent direct interaction between 
osteoclasts and bone matrix (4). In order to allow osteoclasts to attach to the 
bone, the collagen matrix must be removed through collagenase secretion, 
and possibly the lining cells are responsible for this (5).  
Osteocytes 
When bone is formed, some osteoblasts become entrapped in the newly 
formed bone matrix and develop into osteocytes. Osteocytes account for 
approximately 95% of the bone cells, they are long-lived and do not divide 
(4). The osteocytes are located in lacunae and form a network via dendritic 
extensions into canaliculi, which are fluid-filled channels where the cells 
connect to each other. The osteocytes have the capacity to detect mechanical 
pressure and load (6), and thereafter regulate bone remodeling by acting on 
osteoblast and osteoclast differentiation and function (4). 
Osteoclasts 
Osteoclasts are the only cells that can resorb bone (7). They are essential for 
physiological bone resorption during growth, for remodeling, and for 
maintaining calcium homeostasis (8). Osteoclasts originate from 
haematopoietic stem cells, and are formed by fusion of several 
mononucleated cells resulting in large multinucleated cells (9). Osteoclast 
differentiation is promoted by the interaction between receptor activator of 
nuclear factor κB (RANK) ligand, a cytokine expressed by osteoblasts, and 
RANK, expressed on osteoclasts (2). Mature osteoclasts can attach to the 
bone surface, creating an acidic microenvironment that enables bone 
resorption (10). After they have finished resorbing bone, osteoclasts undergo 
apoptosis (2). 
1.4 Bone remodeling 
Bone remodeling is the constantly ongoing process where bone is resorbed 
and formed (11). Just as roads, bridges and buildings, bone develop fatigue 
damage (12). Bone has the unique ability to detect micro-cracks or apoptotic 
osteocytes, remove the damaged bone, and replace it with new bone (13). The 
osteocytes are the cells that sense microcracks and mehanical strain and 
trigger bone remodeling (14). The remodeling cycle begins with recruitment 
Bone density, bone geometry and bone development in young men 
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of osteoclasts for bone resorption and ends with bone formation by the 
osteoblasts, with bone formation lasting approximately three times as long as 
bone resorption (9). This process is completed in approximately 3-6 months 
(1), and takes place in a basic multicellular unit (BMU), consisting of bone 
resorbing osteoclasts, bone forming osteoblasts, osteocytes embedded in bone 
matrix, lining cells and the capillary blood supply (9). Bone remodeling takes 
place throughout the entire skeleton, and it has been estimated that the adult 
skeleton is completely regenerated in 10 years (estimated turnover 10% per 
year for the entire skeleton, considering cortical bone turnover on average 4% 
and trabecular bone turnover on average 28% per year) (5). At the cellular 
level, bone loss occurs because of an imbalance between osteoblast and 
osteoclast activity. For example, oestrogen deficiency after menopause leads 
to enhanced formation of osteoclasts, which causes increased bone turnover 
and progressive loss of trabecular bone (15). Remodeling imbalance causes 
reduced bone strength and can lead to osteoporosis (16). 
1.5 Osteoporosis and its consequences 
Osteoporosis is characterized by low bone density and microarchitectural 
deterioration of bone tissue, leading to an increased risk of fracture (17). The 
incidence increases with age, and at the age of 50, the remaining lifetime 
probability for a fragility fracture in Sweden is around 20% for men and 50% 
for women (18). The most common osteoporotic fractures are fractures of the 
vertebrae (spine), proximal femur (hip) and distal forearm (wrist) (19). 
Osteoporosis and its related fractures are a major public health issue. Patients 
with fractures (especially hip fractures but also vertebral fractures) suffer loss 
of quality of life and mobility, long-term disability and loss of independence 
(20). Only half of those ambulatory before a hip fracture are able to walk 
independently afterwards (21). Fractures also increase the mortality and 
impose a financial burden on the health care system (20). In men, 
osteoporotic fractures occur approximately 5-10 years later in life than in 
women, and after a hip fracture morbidity and mortality rates are higher 
among men (22). Osteoporosis is defined as bone mineral density (BMD) 2.5 
standard deviations (SD) or more below the average of healthy young adult 
women (23). Low BMD is a major risk factor for osteoporotic fracture (24). 
Every SD decrease in BMD is associated with approximately a two-fold 
increase in the age-adjusted hip fracture risk in postmenopausal women, and 
with a three-fold risk increase in elderly men (24-26). Other important risk 
factors for osteoporotic fracture are increasing age, female sex, previous 
fracture, a family history of fracture, and systemic glucocorticoid treatment 
(27-29). Additional risk factors are smoking, excessive alcohol intake and 
Anna Darelid 
5 
low body mass index (BMI), as well as increased risk of falling related to 
visual impairment, treatment with sedatives or reduced mobility (30-33). A 
few years ago, FRAX®, a fracture risk assessment tool developed by the 
WHO, was introduced as a mean to identify patients with high fracture risk. 
It is a country-specific computer-based algorithm available on the internet, 
which calculates fracture probability based on risk factors and patient 
characteristics, with or without available measurements of femoral neck areal 
BMD (aBMD) (34).  
1.6 Bone mineral accrual during growth 
From early childhood to late adolescence, there is an ongoing accumulation 
of skeletal mass, which increases from approximately 70-95 g at birth to 
2400 to 3300 g in young women and men, respectively (35). Skeletal growth 
requires adequate production of growth hormone, thyroid hormones, growth 
factors and sex steroids (36). Before puberty, skeletal growth is largely driven 
by growth hormone. Sex steroids are responsible for epiphyseal maturation 
and mineral accrual during adolescence (36). During childhood and 
adolescence, longitudinal growth as well as changes in skeletal size and 
shape occur (37). Bones become longer through endochondral ossification at 
the growth plates, and wider by periosteal apposition. During puberty, bone 
formation also occurs at the endosteal, inner surface of the cortical bone (37). 
Skeletal modeling during growth differs from bone remodeling, since it leads 
to new bone formation at a different location than the site of resorption, 
resulting in alterations in bone shape and net accrual of bone tissue (38). 
Before puberty, no substantial sex difference has been reported in bone mass 
of the lumbar spine, femur and radius, after adjustment for age, physical 
activity and nutrition (39). During puberty, bone size increases while 
volumetric BMD (vBMD) remains almost constant in both sexes (40). At the 
end of puberty, males have higher BMD, mainly due to greater bone size in 
males compared to females (37). In males, the prolonged bone maturation 
period results in larger increases in cortical thickness and bone size. Cortical 
thickness increases more by periosteal apposition of bone in males, resulting 
in a stronger bone, whereas in females more bone is deposited at the 
endosteal, inner surface (39). There is no significant sex difference in vBMD 
at the end of puberty (40, 41). A large part of the bone mineral content 
(BMC) accrual takes place during the period of adolescent growth 
surrounding peak height velocity (PHV), which is the time of the most rapid 
longitudinal growth. Depending on skeletal site, 33% to 46% of the adult 
BMC has been reported to be accrued in the circumpubertal years (-2 to +2 
Bone density, bone geometry and bone development in young men 
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years from PHV) (42). Thus, this period of life is of great importance in order 
to optimize peak bone mass. 
1.7 Peak bone mass 
During childhood and adolescence, bone mass increases until a plateau is 
reached, the peak bone mass (PBM) (43). The timing of PBM has been 
debated, and differs between the sexes, between different skeletal sites, and 
also between different measurement methods (44-50), but PBM is generally 
believed to be reached in the late teenage years or young adult years (42). 
Achieving a high PBM is considered a key determinant of skeletal health 
throughout life. The bone mass of an individual later in life is a result of the 
peak bone mass accrued, as well as the subsequent rate of bone loss (15). It 
has been proposed that an increase in PBM of 10% (about 1 SD) could delay 
the onset of osteoporosis by 13 years, and could reduce the risk of fracture by 
50% in postmenopausal women (37). Maximizing peak bone mass therefore 
seems to be of great importance in order to reduce the risk of osteoporotic 
fractures. 
1.8 Determinants of peak bone mass 
Heredity is the major determinant of PBM, and approximately 60-80% of the 
variance in PBM has been attributed to genetic factors (36, 51). Several 
environmental factors also influence PBM, among them nutritional intake, 
physical activity and smoking. Key nutritional factors are adequate intake of 
calcium and vitamin D. Association studies between calcium intake and 
BMC or BMD have been performed in children and adolescents, and most, 
but not all, suggest a positive association (52, 53). Several prospective 
randomized controlled trials with calcium supplemention have also 
demonstrated a positive effect on aBMD (53). However, in a review and 
meta-analysis of 19 studies, authors concluded that calcium supplementation 
in healthy children had no effect on aBMD at the hip or spine, but a small 
positive effect was seen on aBMD of the upper limb (54, 55). Few of the 
studies incuded in the review were performed in children with low baseline 
calcium intake. In another meta-analysis, authors concluded that increased 
dietary calcium intake significantly increased total body and lumbar spine 
BMC in children with low baseline calcium intake (56). Vitamin D is 
essential to bone mineralization because of its effects on intestinal calcium 
absorption and on bone mineral accrual (57).  Vitamin D levels in the body 
are influenced by dietary intake, genetic factors, and endogenous synthesis in 
the skin following sunlight exposure, more specifically ultraviolet B (UVB) 
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irradiation (58, 59). In the northern hemisphere at latitudes greater than 40°N 
(north of Madrid), the sunlight is not strong enough to trigger vitamin D 
synthesis in the skin from October to March (59). In a review and meta-
analysis of 6 studies, the authors concluded that it is unlikely that vitamin D 
supplements are beneficial for bone health in children and adolescents with 
normal vitamin D levels, but supplementation in deficient children and 
adolescents could result in clinically important improvements in bone density 
(60, 61). Insufficient serum vitamin D (25(OH)D) levels were recently 
demonstrated to be associated with low aBMD in Finnish children and 
adolescents age 7-19 years (62). In the Finnish study, only 29% of the 195 
subjects had sufficient (>50 nmol/l) vitamin D status over the school year 
(62). The authors concluded that the findings may be representative of other 
Nordic and North European countries. Physical activity seems to be a key 
factor to increase bone mineral accrual during childhood and adolescence. 
The skeleton adapts to the forces and loads it experiences by increasing bone 
mass and remodeling in order to increase strength (63). Weight-bearing 
activities, ideally involving jumping, turning and sprinting, are preferred over 
non weight-bearing activities such as swimming or bicycling when it comes 
to increasing bone mass (64, 65). In children before and during puberty, 
positive effects of weight-bearing exercise on bone have been demonstrated 
in exercise intervention trials (63, 66-68). Recently, larger gains in BMD but 
no increased fracture risk was reported in a study of schoolchildren in 
Malmö, Sweden, taking part in daily physical education during six years 
compared to controls (200 min versus 60 min physical education weekly) 
(69). The authors concluded that a daily physical activity program ought to be 
implemented from school start for all children. Cross-sectional and 
longitudinal observational studies suggest that the beneficial effects of 
physical activity on bone persist into young adulthood (70-72). In the GOOD 
study, men who increased their physical activity between baseline (18-20 yrs) 
and follow-up (23-25 yrs) had an advantageous development of aBMD, 
trabecular vBMD, and cortical bone size (73), indicating that also in young 
adulthood, physical activity has a positive effect on bone development. 
Another lifestyle factor potentially influencing peak bone mass is smoking. 
Smoking has been associated with reduced bone mass and increased fracture 
risk in adult men and women (30, 74-76). Less is known about the effect of 
smoking at the time of peak bone mass accrual, but studies have 
demonstrated a negative relationship between smoking and BMD in both 
male and female adolescents (77-79). In the GOOD cohort, cross-sectional 
data showed that smoking was associated with lower aBMD of especially the 
femoral neck, and reduced cortical thickness of the radius and tibia at age 18-
20 years (80), and longitudinal data demonstrated that smoking was 
associated with impaired bone mass development in young adulthood (81).  
Bone density, bone geometry and bone development in young men 
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1.9 Pubertal timing and peak bone mass  
Another variable suggested to influence peak bone mass is pubertal timing 
(39). Late menarche has been associated with low aBMD and compromised 
microstructure of the radius and tibia in young adult women (124 women, 
20.4±0.6 years (mean±SD)) (82, 83). Areal BMD at all sites was 
demonstrated to be inversely related to pubertal timing in teenagers of both 
genders, in a healthy cohort with variations in pubertal timing within the 
normal range (78 girls and 85 boys, 15.1±1.0 and 16.2±0.9 yrs at follow-up, 
respectively) (84). Results from another study showed lower BMC in late 
maturing males and females at 13-15 years of age, however, in late 
adolescence and young adulthood (17-28 years of age), no significant 
differences in BMC in early, middle, and late maturing men were seen, while 
late maturing females developed less bone mass throughout adolescence than 
their early and average maturing peers (85). In the GOOD study, pubertal 
timing in relation to BMD and bone size was investigated cross-sectionally 
(642 men, 18.9±0.5 years), demonstrating that late pubertal timing was 
associated with lower aBMD at all measured sites, lower cortical and 
trabecular vBMD in both the radius and tibia, as well as reduced cortical 
thickness of the radius and tibia (86). In order to establish whether these 
deficits remain in adulthood, longitudinal studies are needed. 
1.10 Fractures during growth 
More than one in three children suffers a fracture during growth (87, 88), and 
boys have a higher risk than girls of sustaining a fracture in the first 16 years 
of life (89). It has been established that low aBMD is associated with 
prevalent fractures in children as well as in adults (90-94), and it has been 
suggested that fractures during childhood could be a predictor of low peak 
bone mass and persistent bone fragility (95). A recently published 27-year 
prospective longitudinal study demonstrated that in men, a childhood fracture 
was associated with low BMD and smaller bone size in adulthood (age 30-44 
years), while in women, the deficit did not reach statistical significance (96). 
In contrast to this finding, there was no association between a self-recalled 
childhood fracture and future fractures in a large cohort study (97). The peak 
incidence of fractures is at the age of 11 to 12 years among girls and 13 to 14 
years among boys (88, 90, 98, 99), which coincides with the age at peak 
height velocity, but fracture incidence has not previously been investigated 
directly in relation to PHV. Studies have demonstrated that age at PHV 
preceeds the peak in bone mass accrual by approximately one year (100, 
101). The delay in bone mass accrual in relation to linear growth has been 
suggested to cause a transient skeletal deficit in bone mass and 
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mineralization, increasing the susceptibility to fractures at this period in life 
(95, 102). Previous studies have mainly used dual energy X-ray 
absorptiometry (DXA) technique when assessing bone mass in relation to 
fractures in children and adolescents, and consequently it has not been 
clarified whether it is deficits in bone density or bone size that is the main 
contributor to fractures during growth. 
1.11 Bone turnover markers 
In recent years, attention has been drawn to the use of bone turnover markers 
(BTM) in the evaluation of osteoporosis treatment (103-106), and also as a 
determinant of fracture risk (107-109). Bone turnover markers are substances 
that reflect bone turnover and can be measured in samples of blood or urine. 
They can be divided into two categories: bone formation markers, which 
reflect osteoblast activity, and are byproducts of collagen synthesis, matrix 
proteins or osteoblastic enzymes; and bone resorption markers, which reflect 
osteoclast activity and are mainly degradation products of type 1 collagen 
(38). A common bone formation marker is osteocalcin (OC), produced by 
osteoblasts during osteoid synthesis (110). It is incorporated directly into 
bone matrix, but some newly synthesized and secreted OC circulates in blood 
(111). One of the bone resorption markers used is N-terminal telopeptide 
fragment (NTX), a collagen degradation fragment which, when bone is 
resorbed, is released into the blood and subsequently excreted in urine (112). 
It can be measured in serum (sNTX) or urine (uNTX). Several other markers 
of bone turnover are available. Bone turnover during growth can roughly be 
divided into four periods: infancy, prepubertal period, puberty and the 
postpubertal period, with corresponding changes in the levels of BTM (111). 
During puberty, levels of bone turnover markers increase, and have been 
demonstrated to be higher in early puberty and midpuberty compared to 
advanced puberty (113-115). If measurement of bone turnover markers can 
predict bone development around the time of peak bone mass has not 
previously been investigated, but is one of the foci of the present thesis. 
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1.12  Techniques for measuring bone 
density 
1.12.1  Dual energy X-ray absorptiometry (DXA) 
The DXA scanner was introduced in the late 1980s, and is the most widely 
used technique to assess bone density. In order to separate dense tissue from 
soft tissue, the DXA scanner produces txo X-ray beams, one with high 
energy and one with low energy. For each beam, the amount of X-ray that 
passes through the body is measured, and bone density can be calculated. The 
radiation dose from a DXA examination is very low, ranging from 1-10 µSv 
for a spine and hip examination, which is comparable to the daily natural 
background radiation (116). The procedure is painless and noninvasive. In 
clinical use, DXA is primarily used to measure BMD of the lumbar spine and 
femoral neck. These measurements are used to diagnose osteoporosis, assess 
fracture risk, or monitor response to treatment. In postmenopausal women, 
the interpretation of the results are made in comparison to T-scores. A T-
score equal to or less than -2.5 means that the BMD value lies 2.5 SDs or 
more below the average value in young adult women, and indicates 
osteoporosis according to the WHO classification of osteoporosis from 1994 
(117). In younger individuals, Z-score is used instead of T-score. The Z-score 
represents the number of SDs that a given value for BMD deviates from the 
average value for the respective age and gender (118). Limitations with the 
DXA technique include that it renders two-dimensional projection images. 
The BMC of a given area is measured, and BMD (aBMD) is calculated by 
dividing BMC with area (g/cm2). Thus, no consideration is given to the depth 
or volume of the bone, which means that a smaller bone can be falsely 
interpreted as having a low BMD. This is particularly a problem when 
measuring children (116). Measurement errors also occur because of the 
heterogeneity in soft tissue composition in different persons (accuracy error). 
The precision errors are smaller than the accuracy errors because when a 
person is rescanned, the effect of adipose tissue on the measurement is the 
same. Results and radiation dose can differ somewhat when using DXA 
scanners from different manufacturers (116). 
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Figure 2. Images assessed by DXA (Hologic Discovery W). A) Total body B) Total 
hip C) Lumbar spine.
 
1.12.2  Peripheral quantitative computed 
tomography (pQCT) 
Computed tomography is an X-ray based technique that provides three-
dimensional information on morphology and composition of the scanned 
area. The peripheral quantitative computed tomography (pQCT) is a QCT 
device designed to measure peripheral bones, typically the distal forearm 
(radius) and the distal tibia (119). The radiation dose is low, less than 3 µSv 
for a single slice and increases in a multiple-slice protocol (120, 121). Unlike 
DXA, the pQCT renders cross-sectional images. This enables the separation 
of cortical and trabecular bone, so that vBMD of the cortical and trabecular 
bone compartments can be determined separately. It also allows for 
investigation of the geometrical bone properties. Information about trabecular 
bone traits are obtained through a scan at 4% of the bone length in the distal 
direction of the proximal end of the bone, while information about cortical 
bone traits is obtained through a scan at 15-65% of the bone length in the 
distal direction of the proximal end of the bone. Apart from vBMD of the 
trabecular and cortical bone, cortical thickness, cortical CSA, endosteal and 
periostal circumference can be obtained, which enables us to study size and 
density of the bone separately.   
 
! ! ! 
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1.12.3  High resolution pQCT (HR-pQCT) 
Recently, a multislice high-resolution pQCT has come into use. A HR-pQCT 
is a pQCT device that performs several cross-sectional slices and produces a 
three-dimensional image of the bone. The resolution is high (slice thickness 
82 µm) and enables investigation of the microstructure of the trabecular bone: 
the number of trabeculae, trabecular thickness, and how far separated the 
trabeculae are.  
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2 AIM 
The general aim of the thesis was to study the development of bone density 
and bone geometry in young men around the time of peak bone mass, and to 
evaluate the association between pubertal timing and bone development in 
this period of life. In addition, the aim was to investigate whether bone 
turnover markers could predict bone development in young men, and also to 
establish if fracture during childhood and adolescence was related to bone 
density and bone geometry in young adulthood. 
The specific aims of the papers included in the thesis were: 
 
I. To determine if it is the bone size or the vBMD that is most 
strongly associated with X-ray-verified prevalent fractures 
during childhood and adolescence in young men. 
 
II. To investigate the site-specific development of bone 
geometry, aBMD, and vBMD in young men during a five-
year follow-up period, between the age of 19 and 24 years. 
 
III. To establish if pubertal timing is related to the development 
of bone geometry, BMC, aBMD, and vBMD in young men 
between the age of 19 and 24 years, and also to determine if 
late puberty is associated with remaining low bone mass in 
young adulthood in men. 
 
IV. To evaluate if baseline measurements of OC and NTX could 
predict the development of bone geometry, BMC, aBMD, 
and vBMD in young men between the age of 19 and 24 
years. 
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3 MATERIALS AND METHODS 
3.1 Subjects 
All papers included in the thesis are based on the Gothenburg Obesity and 
Osteoporosis Determinants (GOOD) Study. The GOOD study is a 
population-based study with the aim to determine both environmental and 
genetic factors involved in the regulation of bone mass and fat mass. After 
being randomly identified using national population registers, subjects were 
contacted by telephone and asked to participate in the study. In order to be 
included in the GOOD study, subjects had to be between 18 and 20 years of 
age and willing to participate in the study. No other exclusion criteria were 
used. 48.6% of the contacted men agreed to participate and were included in 
the study. In total, 1068 men, 18.9±0.9 years of age, from the greater 
Gothenburg area were included. The GOOD cohort was found representative 
of the general young male population in Gothenburg (48). Five years after the 
baseline visit, the men were contacted by letter and telephone and asked to 
participate in the follow-up study. 112 men could not be reached, and 107 
men declined to participate, leaving 833 men included in the five-year 
follow-up study.  
3.2 Anthropometrics and questionnaires 
Height was measured with a wall-mounted stadiometer, and weight was 
measured to the nearest 0.1 kg. A self-administered questionnaire was used 
both at baseline and follow-up to collect information about nutritional intake, 
fracture history, and physical activity pattern. Calcium intake was calculated 
from reported dairy consumption. Blood samples were drawn and stored at    
-80°C until analysis. 
3.3 Estimation of age at peak height 
velocity (PHV) 
Out of the 1068 subjects included in the GOOD study, complete growth 
charts were available for 642 subjects. Age and BMI did not differ between 
the subset with available growth charts and the complete cohort, indicating 
that the subset is representative for the complete GOOD cohort (86). Growth 
charts were used for determination of age at peak height velocity according to 
the infancy-childhood-puberty (ICP) model. The ICP model isolates three 
distinct components of growth (infancy, childhood, and puberty) that can be 
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described using three different mathematical functions (122, 123). Age at 
PHV was defined as the age at maximum growth velocity during puberty, 
and was estimated by the algorithm. Age at PHV is the most common 
indicator of maturity used in longitudinal studies (85), and is generally 
believed to be reached within 2 years of pubertal onset (123, 124).  
3.4 X-ray registers 
In order to verify reported fractures, X-ray registers were searched. We 
searched the centralized computerized X-ray registers containing radiographs 
and reports from radiologists from 1991 onwards from the public hospitals in 
Gothenburg (Sahlgrenska, Mölndal and Östra (including Queen Silvia’s 
children’s hospital)). Computerized registers were also searched in the small 
private hospitals (Carlanderska and Lundby). A central archive containing X-
ray reports from the entire Västra Götalandsregionen (a region encompassing 
a large part of southwestern Sweden with approximately 1.5 million 
inhabitants) of earlier dates was searched manually using social security 
numbers, as was the local archive of the Queen Silvia’s children’s hospital in 
Gothenburg. The fractures were classified according to skeletal site, based on 
the radiologist’s report. No information concerning trauma severity was 
available. Subjects reporting fractures that could not be verified in the records 
were excluded from analysis. 
3.5 Measurements of bone density 
At both the baseline and the follow-up visit, the subjects underwent 
measurements with DXA and pQCT. At the follow-up visit, subjects also 
underwent examination with HR-pQCT (results not presented in this thesis). 
Dual energy X-ray absorptiometry (DXA) 
BMC (g), bone area (cm2), and aBMD (g/cm2) of the total body, femoral neck 
and total hip (of the left leg), and the left and right radius were assessed at 
baseline and follow-up using the Lunar Prodigy DXA (GE Lunar Corp. 
Madison, WI, USA). The Lunar Prodigy DXA used at the follow-up visit was 
not the same specimen used at the baseline visit. A cross-calibration between 
the two Lunar Prodigy DXA machines was performed at the time of follow-
up and is described in detail in paper II. One person performed all the 
measurements of the baseline study, and another person performed all the 
measurements of the follow-up study. The CVs for the aBMD measurements 
ranged from 0.5-3%, depending on application. 
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Peripheral quantitative computed tomography (pQCT) 
A pQCT device (XCT-2000; Stratec Medizintechnik, GmbH, Pforzheim, 
Germany) was used to scan the distal arm (radius) and the distal leg (tibia) of 
the nondominant arm and leg, respectively. A 2-mm-thick tomographic slice 
was scanned with a voxel size of 0.50 mm. The cortical vBMD (not including 
the bone marrow) (mg/cm3), cortical cross-sectional area (CSA; mm2),
endosteal circumference (EC; mm), periosteal circumference (PC; mm) were 
measured using a scan through the disphysis (at 25% of the bone length in the 
proximal direction of the distal end of the bone) of the radius and tibia. The 
threshold for cortical bone was 711 mg/cm3. Polar strength strain index of the 
cortex (SSI; mm3), was calculated by the software, version 6.00 of the XCT-
2000. SSI represents an estimation of the mechanical strength of the cortical 
bone (125). Trabecular vBMD (mg/cm3) was measured using a scan through 
the metaphysis (at 4% of the bone length in the proximal direction of the 
distal end of the bone) of these bones. Trabecular vBMD was assessed using 
the inner 45% of these bones. Tibial bone length was measured from the 
medial malleolus to the medial condyle of the tibia, and length of the forearm 
was defined as the distance from the olecranon to the ulna styloid process. 
Measurements at the follow-up visit were made using the same procedure and 
the same equipment as at the baseline visit. One person performed all the 
measurements of the baseline study, and another person performed all the 
measurements of the follow-up study. The CVs were less than 1% for all 
pQCT measurements. 
Figure 3. To the left, a scan through the metaphysis of the radius (and ulna) for 
measuring trabecular vBMD. To the right, a scan through the diaphysis of the radius 
(and ulna) for measuring cortical vBMD and cortical geometry. (XCT-2000; Stratec 
Medizintechnik, GmbH, Pforzheim, Germany) 
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3.6 Ethical considerations 
The ethical considerations concerning the GOOD study included radiation 
exposure of study participants. Although DXA and pQCT are techniques 
with very low radiation, there is a small additional exposure. In the follow-up 
study, when participants were examined with DXA, pQCT and HR-pQCT, 
the effective radiation dose was estimated to 0.2 mSv, which corresponds to 
approximately 2 months of background radiation. At baseline, the dose was 
even lower since only DXA and pQCT measurements were performed. 
Venous blood sampling is an invasive procedure, but with minimal risks of 
complications. There is also the question of personal integrity. The data was 
collected in a database where personal data only existed in coded form, and 
consequently no connection between particular individuals and data could be 
made. Only authorized persons had access to the database. The results have 
been presented on a group level, so that no individual can be identified. 
Participants could withdraw from the study at any point. Written and oral 
informed consent was obtained from all included subjects. The regional 
ethical review board at the University of Gothenburg approved all studies 
included in the thesis. 
3.7 Statistics 
Differences in anthropometric characteristics and bone parameters in paper I 
(fracture/non-fracture) were investigated using an independent samples t-test, 
in paper II (baseline/follow-up) using a paired-samples t-test, and in paper III 
(early/middle/late puberty) and IV (quartiles of OC level) using one-way 
ANOVA followed by Bonferroni post hoc test. Chi-square test was used in 
all papers to compare categorical variables. To evaluate the association 
between prevalent fracture and bone variables (paper I) and age at PHV 
(paper III), binary logistic regression analysis was performed. Linear 
regression equations including covariates height, weight, smoking, calcium 
intake and physical activity were performed in order to calculate adjusted 
baseline and 5-year bone variables and the 5-year changes (also adjusted for 
follow-up time) in bone variables (paper II). To determine which variables 
were independent predictors of the change over 5 years in different bone 
variables, stepwise multiple linear regression analyses were performed (paper 
III-IV). The stepwise selection process criterion for entry into the model was 
a p-value ≤0.05, and the criterion for removal from the model was a p-value 
≥0.10.  The percentage of the variation (R2) of the change over five years in 
each bone parameter explained by different variables was calculated using 
the stepwise linear regression model (paper III-IV). Bivariate correlations 
were calculated using Pearson’s correlation (paper II and IV). Parameters that 
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did not display a normal distribution were logarithmically transformed before 
being entered into the regression analysis. In paper IV, a spline regression 
model was used to study the linearity of the association between OC and 
changes in BMD in more detail. A p value less than 0.05 was considered 
significant. Data was analyzed using SPSS software for Windows (paper I, 
version 16.0, paper II version 15.0 and 19.0, paper III version 19.0, paper IV 
version 20.0). 
Statistical	  methods	  
used:	  
Paper	  I	   Paper	  II	   Paper	  III	   Paper	  IV	  
Independent	  
samples	  t-­‐test	  
x	   	   	   	  
Paired	  samples	  t-­‐
test	  
	   x	   	   	  
ANOVA	  and	  post	  hoc	  
test	  
	   	   x	   x	  
Chi	  square	  test	   x	   x	   x	   x	  
Binary	  logistic	  
regression	  
x	   	   x	   	  
Linear	  regression	   	   x	   x	   x	  
Bivariate	  correlation	   	   x	   	   x	  
Log	  transformation	   x	   x	   x	   x	  
Spline	  regression	  
model	  
	   	   	   x	  
 
Table 1. The different statistical methods used in papers I-IV. 
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4 RESULTS AND DISCUSSION 
4.1 Paper I 
Trabecular volumetric bone mineral density is associated with 
previous fracture during childhood and adolescence in males: 
the GOOD study 
In the first study in the thesis, we investigated the association between 
fracture during childhood and adolescence and aBMD, vBMD and bone 
geometry in young adulthood. 304 men were identified as having had at least 
one previous X-ray-verified fracture, while 687 men were non-fracture 
subjects.  
4.1.1 Main results 
 
• Men with prevalent fracture had  
 
Ø lower aBMD than men without fracture at all measured sites 
(total body, lumbar spine, total hip, radius). 
 
Ø lower cortical and trabecular vBMD of the radius and tibia, as 
well as slightly reduced cortical thickness of the radius due to a 
larger endosteal circumference. 
 
• Trabecular vBMD of the radius was most strongly associated with 
previous fracture (radius fracture as well as any fracture). 
 
• Among distal forearm fractures, fracture of the nondominant arm (mostly 
the left arm) was clearly overrepresented. 
 
• Fracture incidence was shown to reach its peak at age at PHV, followed 
by a sharp decline thereafter (fig 4). 
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Figure 4. Fracture incidence according to PHV. Fracture incidence increased with 
advancing age and reached its peak at the time of PHV, followed by a sharp decline 
thereafter. From Darelid et al, JBMR (126). Reprinted with permission from the 
publisher. 
4.1.2 Conclusion 
In conclusion, previous fracture was associated with lower aBMD at all 
measured sites and lower vBMD, especially trabecular vBMD of the radius 
and tibia.  
4.1.3 Discussion 
304 out of 991 men (30.7%) of the men had experienced a fracture during 
growth, which corresponds to other reports of fracture incidence in males in 
this age group (88). When we analyzed the distribution of forearm fractures, 
we found that fracture of the nondominant arm (mostly the left arm) was 
clearly overrepresented. In a previous study of the same cohort, aBMD was 
demonstrated to be higher in the dominant arm than in the nondominant arm, 
indicating that lower aBMD of the nondominant arm may have contributed to 
this distribution (127). Fracture incidence was shown to reach its peak at age 
at PHV, followed by a sharp decline thereafter (fig 4). Several earlier studies 
have demonstrated a peak in fracture incidence of approximately 11-12 years 
for girls and 13-14 years for boys (88, 98, 128), which coincides with age at 
PHV.  To the best of our knowledge, this is the first study ever to investigate 
fracture incidence in direct relation to age at PHV. Our findings indicate that 
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the skeleton is most susceptible to fracture when longitudinal growth is at its 
peak, which corresponds well to earlier findings that body size-corrected 
aBMD decreases to its minimum during age at PHV (102). Our results 
suggest that a reduction in trabecular vBMD, possibly in combination with 
reduced cortical thickness, could be responsible for this reduction in aBMD 
at the time of PHV. Taes and colleagues presented similar results in a study 
of adult men (25-45 years), although in that study cortical thickness was 
more strongly associated with childhood fracture than trabecular vBMD 
(129). In younger boys (15.2±0.5 years (SD±mean) at follow up), Chevalley 
et al demonstrated an association between fracture and lower femoral neck 
aBMD and lower trabecular vBMD of the tibia, due to a reduction in 
trabecular number as measured with HR-pQCT (130). The same authors 
reported that fractures were associated with lower aBMD and lower 
trabecular vBMD of the radius, as well as reduced trabecular thickness in 
young adult women (20.4±0.6 years, mean±SD), findings in concordance 
with the present study (131). Farr and colleagues concluded in a study of 465 
girls 8-13 years old, that previous fracture was associated with lower 
trabecular vBMD, but not bone size, of the femur and tibia (132). In the five-
year follow-up of the GOOD study, Rudäng et al investigated the association 
between childhood fractures and trabecular bone microstructure. Men with a 
childhood fracture (fracture ≤16 years of age) had lower trabecular bone 
volume fraction at both the radius and tibia, mainly due to smaller trabecular 
thickness but also increased trabecular separation, and at the radius also 
reduced trabecular number (133). The assumption that fractures in childhood 
may predict low peak bone mass was recently supported in a 27-year 
prospective study in men (96). In order to improve fracture risk prediction 
and develop prevention strategies, increased knowledge about the etiology of 
bone fragility is valuable. 
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4.2 Paper II 
Cortical consolidation due to increased 
mineralization and endosteal contraction in young 
adult men: a five year longitudinal study 
The second study was a longitudinal study investigating the normal 
development of aBMD, vBMD and bone geometry in young adulthood in 
men. Out of the 1068 men originally included in the GOOD study, 833 men 
agreed to participate in the five-year follow-up study.  
4.2.1 Main results 
 
• Areal BMD of the total body, lumbar spine and radius increased by 3.4%, 
4.2% and 7.8%, respectively, over the five-year period.  
 
• Areal BMD of the total hip and femoral neck decreased by 1.9% and 
3.6%, respectively. 
 
• Both cortical and trabecular vBMD of the radius increased, as well as 
cortical thickness of the radius due to a decreased endosteal 
circumference (fig 5). At the tibia, similar results were seen except for 
trabecular vBMD which decreased slightly. There was a suggested 
decrease in periosteal circumference of the tibia. 
 
• The men included in the follow-up study were substantially heavier and 
slightly taller than at baseline five years earlier. Their reported calcium 
intake and weekly amount of physical activity were reduced compared to 
the baseline visit. 
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Figure 5. Increased mineralization and increased cortical thickness due to 
diminished endosteal circumference in young men between age 18-20 and 23-25 
years. From Ohlsson and Darelid et al, JCEM (134). Reprinted with permission from 
the publisher. 
 
 
4.2.2 Conclusion 
In conclusion, aBMD decreased at the hip but increased at the spine and 
radius, and the increment in the long bones was explained by increased 
vBMD and increased cortical thickness due to endosteal contraction. 
4.2.3 Discussion 
Not many large, population-based longitudinal studies around the time of 
peak bone mass in males have been performed. To the best of our knowledge, 
the present study is the only one using pQCT, which enables us to elucidate 
whether change in density or size of the long bones explains the changes in 
aBMD during this period in life. In a cross-sectional analysis of the GOOD 
cohort, Lorentzon et al demonstrated that age was not correlated to aBMD of 
the lumbar spine, femoral neck and total body in men between 18-20 years, 
results that suggested that PBM had been reached at these sites (48). Radius 
aBMD was correlated to age, as was cortical thickness, EC and cortical 
vBMD of the radius, suggesting ongoing mineralization and increase in bone 
size in the long bones at 18-20 years of age (48). Results from the present 
study show that peak bone mass had been reached in the hip region, since 
aBMD already started to decrease in men between 19 and 24 years. In a 
longitudinal study including 527 men (16-40 years old), authors concluded 
that peak bone mass at the hip occurred between 19 and 21 years of age, 
findings relatively consistent with the present study (135). Similar results, 
with the peak in hip BMC observed at approximately 18.5 yrs (and for 
 18-20 YEAR-OLD 23-25 YEAR-OLD
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femoral neck BMC 16.5 years) was reported by Baxter-Jones et al in a study 
with a mixed longitudinal design (42). Yet earlier, at approximately 16 years, 
was the estimated PBM of aBMD at the hip in a longitudinal study by 
Bachrach et al (136). Nilsson et al demonstrated that a reduced level of 
physical activity between baseline and follow-up was associated with greater 
loss of hip aBMD in the GOOD cohort (73). We hypothesize that weight-
bearing bones are more dependent on continued physical activity in order to 
minimize bone loss. Study participants in the GOOD cohort who started to 
smoke between baseline and follow-up also lost more in total hip and femoral 
neck aBMD (81). There was an increase of 4.2% in lumbar spine aBMD 
between baseline and follow-up, suggesting that in the GOOD cohort, peak 
bone mass was not reached before 18 years of age but between 18-25 years or 
later. Lumbar spine PBM was reported to occur between 19-33 years of age 
in the aforementioned study by Berger et al (135), and the peak in lumbar 
spine BMC was at approximately 18.5 years in the study by Baxter-Jones et 
al (42). In the cohort investigated by Bachrach et al, lumbar spine peak 
aBMD was already reached by approximately 18 years (136). Also aBMD of 
the radius continued to increase (on average 7.8%) between 19 and 24 years 
in the GOOD cohort, and further investigation with pQCT elucidated that this 
increase was due mainly to increased cortical vBMD and greater cortical 
thickness as a result of reduced endosteal circumference. Thus, the process 
suggested in the cross-sectional analysis of the GOOD cohort at 18-20 years 
was confirmed, and continued until 23-25 years of age and possibly longer. A 
longitudinal study including 88 males (22-39 years at baseline) demonstrated 
increases in aBMD of the radius during a 4-year follow-up period (137), and 
a Norwegian population-based longitudinal study using single X-ray 
absorptiometry to investigate distal radius estimated peak bone mass in males 
to 34 years (138). Those results support the conclusion that PBM has not yet 
been reached at the radius in the GOOD cohort. In summary, peak bone mass 
appears to be reached at the hip region already before or around 18 years of 
age, followed by the spine in late teenage years or in the twenties, and in the 
long bones well after that. In the vast majority of studies, females reach PBM 
before males at all sites.  
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4.3 Paper III 
Catch up in bone acquisition in young adult men 
with late normal puberty 
In the third study, we investigated longitudinal development of aBMD, BMC, 
vBMD and bone geometry in relation to age at PHV. 501 men with available 
data on age at PHV participated in the baseline and follow-up study and were 
included in this study. We knew from previous results that men with late (but 
within the normal range) puberty had lower aBMD at age 18-20 years. The 
cohort was divided into tertiles according to age at PHV. Our aim was to 
determine if this deficit persisted into early adulthood, and to investigate 
whether pubertal timing influenced bone development in young adulthood.  
4.3.1 Main results 
 
• Men with late puberty  
 
Ø had significantly larger increases in aBMD and BMC of the total 
body, lumbar spine and radius than men with early puberty.  
 
Ø lost less in femoral neck aBMD. 
 
Ø gained significantly more in cortical and trabecular vBMD of the 
radius, as well as in cortical CSA and PC of the radius.  
 
• Age at PHV was an independent positive predictor of  
 
Ø the increase in aBMD and BMC of the total body, lumbar spine 
and radius (fig 6). 
 
Ø the increase in trabecular and cortical vBMD of the radius. 
 
Ø the increase in cortical CSA and thickness of the radius. 
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• At age 23-25, no significant differences were seen between men in the 
different pubertal groups at the measured bone sites except for radius 
aBMD, which was still lower in men with late puberty due to lower 
cortical and trabecular vBMD. 
 
Figure 6. Age at PHV predicts increase in radius aBMD between 19 and 24 years. 
Higher age at PHV is associated with a larger increase in radius aBMD between 19 
and 24 years of age. From Darelid et al, JBMR (139). Reprinted with permission 
from the publisher. 
4.3.2 Conclusion 
In conclusion, our results demonstrate that late puberty within the normal 
range was associated with a substantial catch up in aBMD, BMC, vBMD and 
bone size in young adulthood. No significant differences in aBMD or BMC 
of the lumbar spine, femoral neck or total body were seen at age 24 in men 
with late puberty, whereas aBMD of the radius was still significantly lower in 
men with late pubertal onset, due to lower cortical vBMD but not reduced 
bone size. 
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4.3.3 Discussion 
The relationship between pubertal onset and adult bone mineral density has 
been mainly studied in women. Studies have shown that late menarche was 
associated with low aBMD and higher fracture risk at several sites in 
postmenopausal women (140-144), whereas early menarche was associated 
with high aBMD in premenopausal women (145, 146). In more recent studies 
by Chevalley and colleagues, an inverse relationship between aBMD of the 
radius and femoral neck and menarcheal age in young women (20.4±0.6 
years, mean±SD) and in premenopausal women (45.8±3.4 years, mean±SD) 
was observed (82, 83). In the present study investigating changes between 
18-20 and 23-25 years, no significant differences between men with early, 
middle and late puberty in aBMD of the lumbar spine, total hip, femoral neck 
and total body were seen at follow-up (23-25 yrs). Possibly, the effects of late 
puberty on adult BMD and BMC differ in men and women. This assumption 
is supported by the earlier mentioned study presented by Jackowski et al, 
where no significant differences in BMC in early, middle, and late maturing 
men were seen in late adolescence and young adulthood (17-28 years of age), 
while late maturing females developed less bone mass throughout 
adolescence than their early and average maturing peers (85). In the present 
study, there were no significant differences in bone geometry at 23-25 years 
of age, while cortical vBMD of the radius was significantly lower in men 
with late puberty. In women, Chevalley et al demonstrated lower cortical 
density and lower cortical thickness of the radius in young adult women with 
late menarcheal age (83). Due to the longitudinal design of our study, we 
could also investigate the relationship between pubertal timing and bone 
development between 18-20 years and 23-25 years. In most bone variables, 
men with late puberty had larger increases than men with early puberty, and 
we concluded that there is a notable catch up effect in bone acquisition during 
this period of life in men with late puberty. Nevertheless, the lower BMD 
observed in teenagers with late puberty has clinical relevance, since this is a 
period of high fracture incidence. In the present study, 43 out of 155 subjects 
(27.7%) with early puberty had experienced at least one fracture during 
growth or young adulthood, compared to 56 out of 147 (38.1%) men with 
middle, and 62 out of 154 (40.3%) men with late puberty (p=0.049). We also 
observed a 28% increased risk of having had a fracture during growth and 
young adulthood for each year age at PHV increased. Chevalley et al 
demonstrated even larger increases in the risk of having had a fracture with 
increasing age at menarche in young women (131).  
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4.4 Paper IV 
In the final study of the thesis, we investigated whether baseline 
measurements of bone turnover markers could predict bone development in 
young men between age 19 and 24 years. 817 men who took part in the 
baseline and follow-up visit, and had a baseline value of osteocalcin and 
NTX, were included in the present study. The men were divided into 
quartiles according to level of OC. 
4.4.1 Main results 
 
• Men with a high OC level at baseline 
 
Ø had significantly larger increases in aBMD and BMC of the 
lumbar spine compared to men with a low OC level at baseline.  
 
Ø lost less in total hip aBMD and in trabecular vBMD of the tibia. 
 
Ø gained significantly more in trabecular vBMD of the radius, as 
well as in cortical CSA of the radius and tibia.  
 
• Osteocalcin was an independent positive predictor of the increase in 
BMD and BMC of the total body, lumbar spine and radius.  
 
• A high OC level at the age of 19 predicted a favorable development in 
BMC, aBMD (fig 7), vBMD and bone size between 19-24 years of age.  
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Figure 7. Change in lumbar spine aBMD between 19 and 24 years of age according 
to level of OC at baseline. From Darelid et al, JCEM (147). Reprinted with 
permission from the publisher. 
4.4.2 Conclusion 
In conclusion, our results demonstrate that high levels of OC at age 19 was 
associated with larger increases in BMC, aBMD, vBMD and bone size in 
young adulthood, indicating that measuring OC could be of value in the 
evaluation of bone development in a young male. 
4.4.3 Discussion 
In this final study of the thesis, we demonstrated that OC, measured at 
baseline, was an independent positive predictor of bone development in 
young men between 19 and 24 years. In paper II, we reported increases in 
aBMD of the lumbar spine, total body and radius, as well as decreased 
aBMD of the femoral neck and total hip in this cohort (134), indicating that 
this period in life is of importance in maximizing PBM. In paper III, age at 
PHV was demonstrated to be a positive predictor of bone development 
between 19 and 24 years in a subsample of men from the GOOD cohort 
(139). Age at PHV is an objective measurement of pubertal timing, and has 
been shown to be strongly correlated to age at menarche in females (148). 
Data to calculate age at PHV are generally not available in the clinical 
setting. When we divided the men into quartiles according to OC level at 
baseline, we found that men with high (35.2±4.4 ng/ml, mean±SD) OC were 
slightly younger and taller, weighed less, and had experienced age at PHV on 
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average one year later than men with low (17.7±2.3 ng/ml, mean±SD) OC at 
baseline. In previous studies, markers of bone turnover have been 
demonstrated to correlate well with age at PHV (149, 150). One small study 
(n=100) reported a very close correlation between OC levels and the pubertal 
growth spurt (151). We suggest that a young man with high OC at age 19 is 
at a lower maturational level and therefore may increase more in bone 
density, bone mass and bone size, than a man with low OC at this time in life. 
The correlation coefficient for age at PHV and log OC was 0.38 (p<0.001), 
indicating that measuring OC could provide some information about the age 
at PHV and the bone maturational level. Longitudinal studies evaluating 
levels of BTM in relation to bone development are scarce. One five-year 
longitudinal study of 240 men (35-69 years) demonstrated that NTX, 
measured at follow-up, was negatively correlated with the change in aBMD 
at the femoral neck r=-0.21) and could explain 3.8% of the variance of the 
change in femoral neck aBMD (152). In the present study, NTX was 
positively correlated to change in femoral neck BMC (r=0.13) but not aBMD, 
and could not explain any of the variance of the change in femoral neck BMC 
or aBMD. OC, on the other hand, was positively correlated to the change in 
femoral neck BMC and aBMD (r=0.18), and could explain 2.9% of the 
variance of the change in femoral neck aBMD. 
4.5 General discussion 
The two main components influencing an individual’s risk of osteoporosis 
are PBM, achieved by young adulthood, and the subsequent rate of bone loss 
later in life (53). It has been proposed that osteoporosis should be considered 
“a pediatric disease with geriatric consequences” (35). Although a large part 
of the variation in PBM is genetically determined, it is also influenced by 
environmental factors. Achieving optimal PBM requires adequate hormone 
levels, proper nutrition (including sufficient intake of calcium and vitamin 
D), and loading of the skeleton through weight-bearing physical activity. The 
trend of increasing physical inactivity among contemporary youth is a 
concern for overall health (153-155), including the acquisition of optimal 
peak bone mass (156). Increased knowledge about the timing of PBM, as 
well as factors that influence the acquisition of PBM, are valuable in order to 
promote lifestyle choices that support the achievement of optimal PBM, 
which could reduce the risk of osteoporosis later in life. In this thesis, we 
present data from the GOOD study, a longitudinal study of young men 
around the time of PBM. Our results suggest that PBM was reached in the 
hip region in the late teens or early twenties, at the lumbar spine in the mid-
twenties, and in the long bones later than mid-twenties. Having had a fracture 
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during childhood or adolescence was associated with lower BMD, indicating 
that a previous fracture is a risk factor for low BMD in young adulthood in 
males. The peak incidence in fractures coincided with age at peak height 
velocity, supporting the notion that this period in life confers a transient 
skeletal fragility due to a discrepance in longitudinal growth and 
mineralization. Men with late pubertal timing had lower BMD at 18-20 years 
of age, but experienced larger gains in the following 5-year-period, resulting 
in a catch up effect. At 23-25 years of age, there was still a deficit in radius 
aBMD in men with late puberty, due to lower vBMD. We do not know if this 
deficit will persist into old age, or if the men with late puberty will increase 
further in vBMD of the long bones in the next few years. It appears as if late 
puberty has more substantial consequences for BMD in women than in men, 
but more studies are needed in order to clarify this. Possibly, the prolonged 
growth period in boys compared to girls contributes to lessen the effect of 
late puberty on PBM in males. We also showed that a high level of OC at age 
18-20 was associated with larger gains in BMD and bone size in the 
following five years. Possibly, measuring OC could be of help when 
evaluating BMD in a young male, to get an indication of whether bone 
density will continue to increase or if that process has ceased. Further studies 
are needed in order to confirm this. A cross-sectional study performed within 
the GOOD cohort showed that men involved in physical activity more than 4 
hours/week had higher aBMD of the lumbar spine and femoral neck, higher 
trabecular vBMD, and greater cortical thickness of the tibia, than men who 
were sedentary (127). Subjects who started their present amount of physical 
activity (minimum 4 hours/week) before age 13 had higher aBMD of the 
femoral neck, cortical CSA of the tibia, and trabecular vBMD of the tibia, 
than subjects who began at age 13 or later, suggesting that exercise before 
and during puberty is important for the acquisition of peak bone mass (127). 
When followed longitudinally, men in the GOOD cohort who increased their 
physical activity between baseline and follow-up had larger increases in 
aBMD of the lumbar spine and total body (73). They also had a small 
increase in hip aBMD, while men who reduced their level of physical activity 
had a decrease in hip aBMD (73). These results indicate that also in young 
adulthood, physical activity is of importance to optimize peak bone mass. In 
a cross-sectional analysis comparing smokers to non-smokers in the GOOD 
cohort, smokers had lower aBMD of the total body, lumbar spine and femoral 
neck, as well as reduced cortical thickness of the radius and tibia due to larger 
endosteal circumference (80). Men who started to smoke between baseline 
and follow-up gained less in aBMD of the total body and lumbar spine than 
their nonsmoking peers (81). They also lost more in hip aBMD and in 
trabecular vBMD of the tibia, indicating that smoking impairs bone 
development in adolescence and young adulthood.  
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Osteoporosis is a major public health issue, and the burden both 
economically and in terms of individual suffering will most likely increase in 
the years to come. A growing number of people will be getting osteoporosis 
due to increased longevity and a sedentary lifestyle. In children, adolescents 
and young adults, we can promote the achievement of a high peak bone mass 
by ensuring adequate calcium intake, supplementing vitamin D deficiency, 
and encouraging a non-smoking lifestyle with daily physical activity, thereby 
reducing the risk of osteoporosis and fractures later in life. 
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5 CONCLUSION 
In a large cohort of young Swedish men investigated by DXA and pQCT, we 
found that a previous fracture was associated with lower aBMD at age 19, 
and especially with reduced trabecular vBMD of the radius. Between age 19 
and 24 years, femoral neck aBMD decreased while lumbar spine aBMD 
increased. Radius aBMD increased, due to increased cortical thickness and 
continuing mineralization. Men with late puberty had larger gains in aBMD, 
vBMD, and bone size, and lost less in aBMD of the femoral neck, reflecting 
a catch-up in bone acquisition in young adulthood in men with late puberty. 
A high level of OC at age 19 was associated with larger gains in aBMD, 
vBMD, and bone size between 19 and 24 years of age. Even though the 
majority of bone acquisition takes place in the circumpubertal years, this 
thesis indicates that young adulthood is also a period of importance in order 
to attain optimal PBM, which in turn could be crucial for the prevention of 
osteoporosis and fragility fractures later in life. 
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